These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19193545)

  • 61. Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.
    Putzer D; Gabriel M; Henninger B; Kendler D; Uprimny C; Dobrozemsky G; Decristoforo C; Bale RJ; Jaschke W; Virgolini IJ
    J Nucl Med; 2009 Aug; 50(8):1214-21. PubMed ID: 19617343
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical challenges: chemotherapy-induced peripheral neuropathy.
    Paice JA
    Semin Oncol Nurs; 2009 May; 25(2 Suppl 1):S8-19. PubMed ID: 19447319
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cardiac murmur, hepatomegaly, and diarrhea.
    McGuire LB; Smith DE
    Va Med Mon (1918); 1965 Oct; 92(10):484-93. PubMed ID: 5831617
    [No Abstract]   [Full Text] [Related]  

  • 64. Carcinoid tumor and intravenous octreotide infusion during labor and delivery.
    Le BT; Bharadwaj S; Malinow AM
    Int J Obstet Anesth; 2009 Apr; 18(2):182-5. PubMed ID: 19200714
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effectiveness of nursing education as an intervention to decrease fatigue in Turkish patients receiving chemotherapy.
    Yesilbalkan OU; Karadakovan A; Göker E
    Oncol Nurs Forum; 2009 Jul; 36(4):E215-22. PubMed ID: 19581225
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Good oral hygiene practice.
    Moore D; Roach J; Deveney P; Sweedman M
    Aust Nurs J; 2009 Jun; 16(11):46-7. PubMed ID: 19588719
    [No Abstract]   [Full Text] [Related]  

  • 67. [Rectal neuroendocrine tumours].
    Louthan O
    Klin Onkol; 2009; 22(5):195-201. PubMed ID: 19886356
    [TBL] [Abstract][Full Text] [Related]  

  • 68. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: peptide receptor radionuclide therapy with radiolabeled somatostatin analogs.
    Kwekkeboom DJ; Krenning EP; Lebtahi R; Komminoth P; Kos-Kudła B; de Herder WW; Plöckinger U; ;
    Neuroendocrinology; 2009; 90(2):220-6. PubMed ID: 19713714
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Merkel cell carcinoma of the breast].
    Monteagudo Sánchez B; Cabanillas M; Caínzos T; Used-Aznar MM
    Actas Dermosifiliogr; 2009 Mar; 100(2):151-2. PubMed ID: 19445883
    [No Abstract]   [Full Text] [Related]  

  • 70. [Carcinoid of the minor duodenal papilla associated with multiple jejunal leiomyomas in type 1 neurofibromatosis].
    Ghidirim G; Rojnoveanu G; Mişin I; Cernîi A; Gurghiş R
    Chirurgia (Bucur); 2009; 104(4):491-4. PubMed ID: 19886060
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Treatment options for metastatic neuroendocrine tumors.
    Phan AT; Yao JC; Evans DB
    Surgery; 2008 Dec; 144(6):895-8. PubMed ID: 19040994
    [No Abstract]   [Full Text] [Related]  

  • 72. Middle ear adenoma with neuroendocrine differentiation (MEA-ND) in the pediatric population.
    Dogru S; Wilkinson EP; Robinson RA; Smith RJ
    Int J Pediatr Otorhinolaryngol; 2009 Jun; 73(6):895-8. PubMed ID: 19303146
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Broncholithiasis mimicking a bronchial carcinoid tumour.
    Stassano P; Griffo S; Di Tommaso L; Luciano A
    Thorax; 2009 Jun; 64(6):551-2. PubMed ID: 19478128
    [No Abstract]   [Full Text] [Related]  

  • 74. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biochemical markers.
    O'Toole D; Grossman A; Gross D; Delle Fave G; Barkmanova J; O'Connor J; Pape UF; Plöckinger U; ;
    Neuroendocrinology; 2009; 90(2):194-202. PubMed ID: 19713711
    [No Abstract]   [Full Text] [Related]  

  • 75. Molecular target therapy for gastroenteropancreatic endocrine tumours: biological rationale and clinical perspectives.
    Capurso G; Fazio N; Festa S; Panzuto F; De Braud F; Delle Fave G
    Crit Rev Oncol Hematol; 2009 Nov; 72(2):110-24. PubMed ID: 19249226
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gemcitabine and oxaliplatin combination chemotherapy for metastatic well-differentiated neuroendocrine carcinomas: a single-center experience.
    Cassier PA; Walter T; Eymard B; Ardisson P; Perol M; Paillet C; Chayvialle JA; Scoazec JY; Hervieu V; Bohas CL
    Cancer; 2009 Aug; 115(15):3392-9. PubMed ID: 19472402
    [TBL] [Abstract][Full Text] [Related]  

  • 77. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: follow-up and documentation.
    Arnold R; Chen YJ; Costa F; Falconi M; Gross D; Grossman AB; Hyrdel R; Kos-Kudła B; Salazar R; Plöckinger U; ;
    Neuroendocrinology; 2009; 90(2):227-33. PubMed ID: 19713715
    [No Abstract]   [Full Text] [Related]  

  • 78. A genetic cause for skin lumps and diarrhoea.
    Arasaradnam RP; Jarvis H; Waight G; Prajapati R; Adesanya O; Nwokolo C
    Gut; 2009 Mar; 58(3):330, 464. PubMed ID: 19211853
    [No Abstract]   [Full Text] [Related]  

  • 79. Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor.
    Korse CM; Taal BG; de Groot CA; Bakker RH; Bonfrer JM
    J Clin Oncol; 2009 Sep; 27(26):4293-9. PubMed ID: 19667278
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Palliative care is an integral part of comprehensive cancer care.
    Coyle N
    Oncology (Williston Park); 2008 Apr; 22(4 Suppl Nurse Ed):34. PubMed ID: 19856559
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.